MedWatch

Amplifon tops sales expectations

Italian Amplifon had a revenue of EUR 459.1m in Q3, beating analysts' estimates.

Photo: Jens Dresling

The Italian hearing aid retailer has sold more than what analysts have anticipated in the third quarter of the year – margins, however, haven't quite kept up.

Revenue is thus only slightly above the market's consensus estimates.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs